STOCK Parp1tm1a(EUCOMM)Hmgu/IcsOrl

Status

Available to order

EMMA IDEM:10037
International strain nameSTOCK Parp1tm1a(EUCOMM)Hmgu/IcsOrl
Alternative nameHEPD0555_6_C04
Strain typeTargeted Mutant Strains
Allele/Transgene symbolParp1tm1a(EUCOMM)Hmgu
Gene/Transgene symbolParp1
DisclaimerPlease note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
  1. We can not guarantee a null mutation for Knock-out first alleles (tm1a alleles, see http://www.mousephenotype.org/about-ikmc/targeting-strategies) as the critical exon has not been deleted.
  2. That the structure of the targeted mutation in the ES cells obtained from EUCOMM/KOMP to generate EUCOMM/KOMP mice is not verified by INFRAFRONTIER/EMMA. It is recommended that the recipient confirms the mutation structure.
  3. No check for determining the copy number of the targeting construct in ES cells obtained from EUCOMM/KOMP is done by INFRAFRONTIER/EMMA.
  4. The level of quality control before mice are released is to confirm the individual mouse genotype by short range PCR.

Information from provider

Provider ICS, Institut Clinique de la Souris
Provider affiliationICS, Institut Clinique de la Souris
Genetic informationThis mouse line originates from EUCOMM ES clone HEPD0555_6_C04. For further details on the construction of this clone see the page at the IMPC portal.
Phenotypic informationPotential phenotyping data in the IMPC portal
ReferencesNone available

Information from EMMA

Archiving centreInstitut de Transgenose, INTRAGENE, Orléans, France
Animals used for archivingheterozygous C57BL/6NCrl

Disease and phenotype information

IMPC phenotypes (gene matching)
  • decreased grip strength / IMPC
  • decreased total retina thickness / IMPC
  • decreased NK cell number / IMPC
  • preweaning lethality, incomplete penetrance / IMPC
  • abnormal spleen morphology / IMPC
  • abnormal uterus morphology / IMPC
  • abnormal eye morphology / IMPC
  • increased prepulse inhibition / IMPC
  • small seminal vesicle / IMPC
  • immune system phenotype / IMPC
  • increased circulating creatinine level / IMPC
  • increased fasting circulating glucose level / IMPC
  • abnormal seminal vesicle morphology / IMPC
  • microphthalmia / IMPC
  • increased effector memory CD8-positive, alpha-beta T cell number / IMPC
  • enlarged spleen / IMPC
  • abnormal retina inner nuclear layer morphology / IMPC
MGI phenotypes (gene matching)
  • decreased cell proliferation / MGI
  • skin hyperplasia / MGI
  • decreased body weight / MGI
  • increased mortality induced by gamma-irradiation / MGI
  • abnormal inflammatory response / MGI
  • decreased inflammatory response / MGI
  • decreased litter size / MGI
  • abnormal macrophage physiology / MGI
  • enhanced wound healing / MGI
  • no phenotypic analysis / MGI
  • abnormal leukocyte migration / MGI
  • decreased neuron apoptosis / MGI
  • abnormal response/metabolism to endogenous compounds / MGI
  • abnormal microglial cell physiology / MGI
  • elevated level of mitotic sister chromatid exchange / MGI
  • increased mortality induced by ionizing radiation / MGI
  • induced chromosome breakage / MGI
  • decreased susceptibility to kidney reperfusion injury / MGI
  • abnormal cell cycle checkpoint function / MGI
  • decreased susceptibility to noise-induced hearing loss / MGI
  • decreased susceptibility to injury / MGI
  • immune system phenotype / MGI
  • increased renal glomerular filtration rate / MGI
  • decreased circulating creatinine level / MGI
  • increased apoptosis / MGI
  • abnormal DNA repair / MGI
  • decreased circulating tumor necrosis factor level / MGI
  • decreased circulating interleukin-1 beta level / MGI
  • decreased susceptibility to endotoxin shock / MGI
  • decreased physiological sensitivity to xenobiotic / MGI
  • increased sensitivity to induced morbidity/mortality / MGI
  • prenatal lethality, incomplete penetrance / MGI
  • decreased renal tubule apoptosis / MGI
  • decreased susceptibility to dopaminergic neuron neurotoxicity / MGI

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).